Edition:
United States

Anhui Anke Biotechnology Group Co Ltd (300009.SZ)

300009.SZ on Shenzhen Stock Exchange

17.40CNY
22 Sep 2017
Change (% chg)

¥-0.51 (-2.85%)
Prev Close
¥17.91
Open
¥17.87
Day's High
¥17.87
Day's Low
¥17.30
Volume
8,891,611
Avg. Vol
7,030,313
52-wk High
¥20.76
52-wk Low
¥13.94

Chart for

About

Anhui Anke Biotechnology (Group) Co., Ltd is a China-based company principally engaged in the research, development, manufacture and distribution of biological products, Chinese patent drugs, chemical synthetic drugs, peptide drugs and nucleic acid detection products. The Company’s main products include recombinant human... (more)

Overall

Beta: 0.92
Market Cap(Mil.): ¥12,397.89
Shares Outstanding(Mil.): 712.52
Dividend: 0.12
Yield (%): 0.66

Financials

  Industry Sector
P/E (TTM): -- 81.40 16.08
EPS (TTM): -- -- --
ROI: -- 3.18 14.60
ROE: -- 4.93 14.03

BRIEF-Anhui Anke Biotechnology Group adopts new accounting policy

* Says it adopted new accounting policy disclosed by the Ministry of Finance on May 10, regarding subsidy

Aug 08 2017

BRIEF-Anhui Anke Biotech in deal to buy stake in biotechnology firm

* Says it agrees to buy 30 percent stake in biotechnology firm for 105 million yuan ($15.69 million)

Aug 08 2017

BRIEF-Anhui Anke Biotechnology Group sees H1 FY 2017 net profit to up 30 pct to 50 pct

* Sees H1 FY 2017 net profit to increase by 30 percent to 50 percent, compared to net profit of H1 FY 2016 (85.1 million yuan)

Jul 14 2017

BRIEF-Anhui Anke Biotechnology Group unit receives approval for drug clinical trials

* Says its unit has been granted approval for drug clinical trials for cefdinir tablets issued by China Food And Drug Administration

Jul 07 2017

BRIEF-Anhui Anke Biotechnology Group receives patent

* Says it received patent(No. ZL 2014 1 0027089.0) for preparation technology for improving native conformation content of recombinant human interferon alpha2b, valid for 20 years

Jun 12 2017

BRIEF-Anhui Anke Biotechnology (Group) to pay FY 2016 annual div on May 18

May 11 Anhui Anke Biotechnology (Group) Co Ltd : * Says it plans to pay FY 2016 annual div on May 18 Source text in Chinese: https://goo.gl/mMCyCQ Further company coverage: (Beijing Headline News)

May 11 2017

BRIEF-Anhui Anke Biotechnology (Group) to sell pharma unit for 18.4 mln yuan

April 27 Anhui Anke Biotechnology (Group) Co Ltd :

Apr 27 2017

BRIEF-Anhui Anke Biotechnology Group unit gets CEP for drug OXYTOCIN from EDQM

* Says its wholly owned subsidiary Shanghai SOHO-YIMING Pharmaceuticals Co Ltd got Certificate of Suitability to Monograph of European Pharmacopoeia (CEP) for the drug oxytocin API(OXYTOCIN) from European Directorate for Quality of Medicines & HealthCare (EDOM)

Apr 19 2017

BRIEF-Anhui Anke Biotechnology Group announces FY 2016 dividend payment

* To use undistributed profits to pay a cash dividend of 1.5 yuan (pre-tax) per 10 shares to shareholders for FY 2016

Mar 30 2017

BRIEF-Anhui Anke Biotechnology Group unit to set up health industry JV with partners

* Says co's wholly owned unit plans to invest 10 million yuan to set up health industry investment LP with partners and will hold a 49.3097 percent stake in it

Mar 30 2017

Earnings vs. Estimates